Enweida (envafolimab) - 3DMed, Ascletis
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Jemperli (dostarlimab-gxly) - GSK
Keytruda (pembrolizumab) - Merck (MSD)
http://www.ncbi.nlm.nih.gov/pubmed/42621259
 
Katarzyna Wanke; Mateusz Kciuk; Renata Kontek
 
Aug 21, 2026
 
Prev Next